Summary
The responses of twelve patients with chronic asthma to salmefamol 1 mg and 2 mg, taken orally, were compared in a double-blind cross-over study. Both produced a rise of 40 – 50 % in PEFR and FEV1. Statistically significant improvements were maintained for three to four hours, and 20 % improvements for four to six hours. There was no significantly different effect on ventilatory capacity between the two doses. After the 2 mg dose there was a statistically significant fall in diastolic blood pressure at 1 and 1 1/2 hours. Four patients experienced tremor and this was the only side-effect noted. The possible reasons for failure to demonstrate a greater effect with the higher dose are discussed.
Similar content being viewed by others
References
Bartley, D., Jack, D., Lunts, L.H.C., Ritchie, A.C.: New class of selective stimulants of β — adrenergic receptors. Nature (Lond.)219, 861–862 (1968)
Shenfield, G.M., Paterson, J.W.: Clinical assessment of bronchodilator drugs delivered by aerosol. Thorax28, 124–128 (1973)
Sillett, R.W., Dash, C.H., McNicol, M.W.: Comparison of salmefamol with salbutamol aerosols in asthmatics. Europ. J. clin. Pharmacol. (in press) (1975)
Kennedy, M.C.S., Dash, C.H.: The bronchodilator effect of a new adrenergic aerosol — salmefamol. Acta allerg. (Kbh.)27, 22–26 (1972)
Cotes, J.E.: Lung function at different stages in life, including normal values. In: Lung function (2nd Ed.), pp. 345–391. Oxford and Edinburgh: Blackwell Scientific Publications 1968
Evans, M.E., Shenfield, G.M., Paterson, J.W.: The clinical pharmacology of salmefamol. Brit. J. clin. Pharmacol,1, 391–397 (1974)
Watson, J.M., Richens, A.: The effects of salbutamol and terbutaline on physiological tremor, bronchial tone and heart rate. Brit. J. clin. Pharmacol.1, 223–227 (1974)
Cochrane, G.M., Clark, T.J.H., Hanan, M.E.: The role of oral bronchodilator therapy as shown by a comparison between salbutamol and terbutaline. Curr. med. Res. & Opin.1, 517–523 (1973)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sillett, R.W., Dash, C.H. & McNicol, M.W. Salmefamol orally in asthmatics—Two doses compared. Eur J Clin Pharmacol 9, 281–284 (1976). https://doi.org/10.1007/BF00561661
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00561661